Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies

Advancements in adoptive cell therapy over the last four decades have revealed various new therapeutic strategies, such as chimeric antigen receptors (CARs), which are dedicated immune cells that are engineered and administered to eliminate cancer cells. In this context, CAR T-cells have shown signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshavarz, Ali, Salehi, Ali, Khosravi, Setareh, Shariati, Yasaman, Nasrabadi, Navid, Kahrizi, Mohammad Saeed, Maghsoodi, Sairan, Mardi, Amirhossein, Azizi, Ramyar, Jamali, Samira, Fotovat, Farnoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509604/
https://www.ncbi.nlm.nih.gov/pubmed/36153626
http://dx.doi.org/10.1186/s13287-022-03163-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509604/
https://www.ncbi.nlm.nih.gov/pubmed/36153626
http://dx.doi.org/10.1186/s13287-022-03163-w

Ejemplares similares